Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buddy Creech

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
The Journal of Infectious Diseases|February 26, 2015
Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) VaccinePatricia L Winokur, Shital M Patel, Rebecca Brady, et al.
The Journal of Infectious Diseases|August 19, 2011
Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant womenLisa A Jackson, Shital M Patel, Geeta K Swamy, et al.
Open Forum Infectious Diseases|January 30, 2020
Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel <i>Staphylococcus aureus</i> 4-Antigen Vaccine (SA4Ag)C Buddy Creech, Robert W Frenck, Anne Fiquet, et al.
The Journal of Pediatrics|March 27, 2021
Clinical Epidemiology and Outcomes of Pediatric Musculoskeletal InfectionsJumi Yi, James B Wood, C Buddy Creech, et al.
The New England Journal of Medicine|June 29, 2017
A Placebo-Controlled Trial of Antibiotics for Smaller Skin AbscessesRobert S Daum, Loren G Miller, Lilly Immergluck, et al.
Pediatrics|March 28, 2022
Safety of Live Attenuated Influenza Vaccine in Children With AsthmaAndrew G Sokolow, Amy P Stallings, Carolyn Kercsmar, et al.
Journal of the Pediatric Infectious Diseases Society|April 8, 2023
Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in InfantsStephanie L Rolsma, Sandra M Yoder, Rachel S Nargi, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2023
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment AnalysisGuohua An, C Buddy Creech, Nan Wu, et al.
The Journal of Antimicrobial Chemotherapy|April 18, 2023
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patientsGuohua An, C Buddy Creech, Nan Wu, et al.
Proteomics|May 17, 2017
Proteomics show antigen presentation processes in human immune cells after AS03-H5N1 vaccinationAllison C Galassie, Johannes B Goll, Parimal Samir, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Infectious Diseases|February 26, 2015
Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) VaccinePatricia L Winokur, Shital M Patel, Rebecca Brady, et al.
The Journal of Infectious Diseases|August 19, 2011
Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant womenLisa A Jackson, Shital M Patel, Geeta K Swamy, et al.
Open Forum Infectious Diseases|January 30, 2020
Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel <i>Staphylococcus aureus</i> 4-Antigen Vaccine (SA4Ag)C Buddy Creech, Robert W Frenck, Anne Fiquet, et al.
The Journal of Pediatrics|March 27, 2021
Clinical Epidemiology and Outcomes of Pediatric Musculoskeletal InfectionsJumi Yi, James B Wood, C Buddy Creech, et al.
The New England Journal of Medicine|June 29, 2017
A Placebo-Controlled Trial of Antibiotics for Smaller Skin AbscessesRobert S Daum, Loren G Miller, Lilly Immergluck, et al.
Pediatrics|March 28, 2022
Safety of Live Attenuated Influenza Vaccine in Children With AsthmaAndrew G Sokolow, Amy P Stallings, Carolyn Kercsmar, et al.
Journal of the Pediatric Infectious Diseases Society|April 8, 2023
Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in InfantsStephanie L Rolsma, Sandra M Yoder, Rachel S Nargi, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2023
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment AnalysisGuohua An, C Buddy Creech, Nan Wu, et al.
The Journal of Antimicrobial Chemotherapy|April 18, 2023
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patientsGuohua An, C Buddy Creech, Nan Wu, et al.
Proteomics|May 17, 2017
Proteomics show antigen presentation processes in human immune cells after AS03-H5N1 vaccinationAllison C Galassie, Johannes B Goll, Parimal Samir, et al.
Pageof 15